Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04297605
Title Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Rochester
Indications

lung non-small cell carcinoma

Therapies

Pembrolizumab + Pemetrexed Disodium

Nab-paclitaxel + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Rochester Not yet recruiting Rochester New York 14642 United States Details
University of Rochester Recruiting Rochester New York 14642 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field